Testing solutions designed for oncologists
We have developed a suite of products designed to work for every patient, even as cancers evolve. Our test menu is regularly updated to provide solutions that align to the latest evidence and guidelines.

State-of-the-art testing options, including DNA- and RNA-based next-generation sequencing (NGS)

A suite of pan-tumor and disease-specific panels to match the right test to the right indication

Solid tumor liquid biopsy testing to provide minimally invasive genomic testing solutions

Access to a center of excellence for specimen procurement services, including mobile phlebotomy and solid tissue block retrieval

Patient support teams that will partner with you to help your patients navigate their testing journey
Testing solutions by disease area

Breast cancer

Lung cancer

Colorectal cancer

Hematologic cancer

Gastric cancer

Gynecologic cancer

Pan-Solid Tumor
Featured tests
NEO PanTracer Tissue + HRD
NGS comprehensive genomic profile targeting 517 genes in DNA and RNA for SNVs, InDels, CNVs, RNA fusions/splice variants with MSI and TMB for pan-solid tumors, and HRD for ovarian tumors.